World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT02162134
Date of registration: 06/06/2014
Prospective Registration: No
Primary sponsor: Benazir Bhutto Hospital, Rawalpindi
Public title: Does Sugared or Sugar Free Chewing Gum Reduces Postoperative Ileus After Laparoscopic Cholecystectomy
Scientific title: Does Sugared or Sugar Free Chewing Gum Reduces Postoperative Ileus After Laparoscopic Cholecystectomy
Date of first enrolment: January 2013
Target sample size: 90
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT02162134
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  N/A
Countries of recruitment
Pakistan
Contacts
Name:     Fazal Hussain Shah, FCPS-I
Address: 
Telephone:
Email:
Affiliation:  Benazir Bhutto Hospital, Rawalpindi
Name:     Muhammad Zubair Saeed, FCPS-I
Address: 
Telephone:
Email:
Affiliation:  Benazir Bhutto Hospital, Rawalpindi
Name:     Arslan Zahid, FCPS-I
Address: 
Telephone:
Email:
Affiliation:  Benazir Bhutto Hospital, Rawalpindi
Name:     Aurangzeb khan, FCPS
Address: 
Telephone:
Email:
Affiliation:  Benazir Bhutto Hospital, Rawalpindi
Name:     Muhammad Bilal Habshi, FCPS-I
Address: 
Telephone:
Email:
Affiliation:  Benazir Bhutto Hospital, Rawalpindi
Key inclusion & exclusion criteria

Inclusion Criteria

1. Patients undergoing elective laparoscopic cholecystectomy for gallstone disease.

2. Patients with age range of 25 to 55 years

Exclusion Criteria

1. H/O chronic illness like DM, IHD, CRF, CLD

2. Immunocompromised patients.

3. Previous history of any chemotherapy or radiotherapy, any history of repeated
infections, pneumonia.

4. Patients with H/O concurrent intestinal illnesses like Tuberculosis, ulcerative
colitis, Crohn's disease, acute or chronic diarrhea, constipation etc.

5. Previous hepatobilliary surgery.

6. H/O use of antispasmodics, or drugs affecting the intestinal motility within last 72
hours before and after surgery (tricyclic antidepressants, antipsychotics)

7. Patients who develop the postop complications like wound infection, intra-abdominal
collections etc.

8. Complicated cholecystectomy in which laparoscopic cholecystectomy is converted to
open cholecystectomy.

9. Cholecystectomy in which the biliary leakage was complication, either in the drain or
later on detected via ultrasound



Age minimum: 25 Years
Age maximum: 55 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Postoperative Ileus.
Intervention(s)
Drug: Inj. Zantac 50mg IV
Other: sugared chewing gum
Drug: Inj. Cefuroxime 1.5 g IV
Drug: Inj. Propofol 2.5mg/kg
Drug: Sevoflurane 2.5 vol %
Other: sugar free chewing gum
Drug: Tab. Midazolam 7.5 mg
Drug: Inj. Atracurium 0.5 mg/kg
Drug: Inj. Midazolam 0.7mg/kg 45 min before surgery
Drug: Inj. Ketorolac 30 mg IV
Primary Outcome(s)
onset of hunger [Time Frame: 4 hours after surgery until patient feels first feeling of hunger. an expected average of 12 hours.]
onset of defecation [Time Frame: 4 hours after surgery until patient defecated. an expected average of 24 hours.]
onset of flatus passing [Time Frame: 4 hours after surgery until patient passes flatus. an expected average of 18 hours.]
onset of bowel movements [Time Frame: 4 hours after surgery until the bowel sounds are present. an expected average of 10 hours.]
Secondary Outcome(s)
time of surgery [Time Frame: skin incision to skin closure time of surgery. an expected average of 1 hour]
Secondary ID(s)
BenazirBH
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history